Both breast cancer and prostate cancer are often analyzed together; reduced HMGA2, targeted by miR-98, has been speculated to possibly inhibit breast cancer cell proliferation, migration, invasion and promote cell apoptosis [29,30]. Here, HMGA2 is linked to breast carcinoma.